NeuroPace (NPCE) Shares Outstanding (2020 - 2026)

NeuroPace has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $34.3 million in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 3.75% year-over-year to $34.3 million in Q2 2026; TTM through Jun 2026 was $34.3 million, a 3.75% increase from a year earlier, with the FY2025 full-year figure at $33.6 million, up 11.38% from the prior year.
• Shares Outstanding (Entity) was $34.3 million for Q2 2026 at NeuroPace, up from $33.9 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $34.3 million in Q2 2026, with the low at $24.5 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $29.1 million, with a median of $28.9 million recorded in 2024.
• The largest YoY upside for Shares Outstanding (Entity) was 8993.31% in 2022 against a maximum downside of 2.29% in 2022.
• Over 5 years, Shares Outstanding (Entity) stood at $25.0 million in 2022, then increased by 11.09% to $27.8 million in 2023, then gained by 8.34% to $30.1 million in 2024, then climbed by 11.38% to $33.6 million in 2025, then advanced by 2.11% to $34.3 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $34.3 million (Q2 2026), $33.9 million (Q1 2026), and $33.6 million (Q4 2025), per Business Quant data.